http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106946973-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-0005 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
| filingDate | 2017-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106946973-B |
| titleOfInvention | A kind of compound and its preparation method and use |
| abstract | The invention belongs to the field of medicinal chemistry, and in particular relates to a compound and a preparation method and application thereof, namely (3β,22α,25R)-spirosterine alk-5-alkenyl-3-O-β-D-glucopyranosyl -(1→2)-O-[β-D-xylopyranosyl-(1→3)]-O-β-D-glucopyranosyl-(1→4)-β-D-pyran A new use of galactoside and a preparation method thereof, the compound can inhibit lung cancer cells, arrest the growth cycle of lung cancer cells at an early stage, and promote lung cancer cell apoptosis, therefore, the compound can be used for the preparation of anticancer drugs, especially Preparation of anti-lung cancer drugs. |
| priorityDate | 2017-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.